Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-10-01 00:00:00 ET · period of report 2024-09-30 · accession 0001048477-24-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-01 | 2024-09-30 | BMRN | Friberg Gregory R | EVP, Chief R, D Off | A - Grant | $0.00 | +29.1K | 29.1K | New | $0 |
| D | 2024-10-01 | 2024-09-30 | BMRN | Friberg Gregory R | EVP, Chief R, D Off | A - Grant | $0.00 | +49.9K | 49.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | A | A | 21,190 | $0.00 | 21,190 | D | — | — | (F1) Restricted stock units granted on September 30, 2024. Price not applicable. |
| 2 | Common | Common Stock | 2024-09-30 | A | A | 7,870 | $0.00 | 29,060 | D | — | — | (F1) Restricted stock units granted on September 30, 2024. Price not applicable. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-09-30 | A | A | 49,850 | $0.00 | 49,850 | D | $70.29 · 2025-09-30 to 2034-09-29 | 49,850 Common Stock | (F2) Option grant vests 12/48th on September 30, 2025 and 1/48th per month thereafter. |